Abstract
Objective
To examine the variability in neonatologists’ screening and management practices of corticosteroid-induced adrenal insufficiency (adrenal suppression; AS) in the NICU.
Study design
A cross-sectional survey was disseminated nationally via REDCap® to 160 neonatologists who serve as members of Children’s Hospitals Neonatal Consortium. Descriptive statistics were used to capture variability in AS screening modalities, diagnostic tools, management approaches, and discharge planning.
Result
Of the 82 respondents, only 56.1% screen infants for AS following prolonged systemic corticosteroid exposure, 46.3% after 2–4 weeks, 59.8% utilizing ACTH stimulation testing. Only 2.4% screen after prolonged high dose inhaled corticosteroids, reflecting uncertainty regarding their suppressive potential. Additionally, only 30.5% provide structured caregiver AS education at discharge.
Conclusion
Variable nationwide screening and management of adrenal suppression in the NICU underscores uncertainty and inconsistency in practice, revealing the need for clinical guidelines to optimize care.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Neonatal Group, editor. Cochrane Database Syst Rev [Internet]. 2017 [cited 2025 May 25];2018. Available from: http://doi.wiley.com/10.1002/14651858.CD001146.pub5
Htun ZT, Schulz EV, Desai RK, Marasch JL, McPherson CC, Mastrandrea LD, et al. Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia. J Perinatol. 2021;41:1783–96.
Tang M, Ibrahim A, Laughon C, Moore K, Tejada A, Tran D, et al. Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit. J Perinatol. 2024;44:953–6.
Ryan RM, Keller RL, Poindexter BB, D’Angio CT, Shaw PA, Bellamy SL, et al. Respiratory medications in infants <29 weeks during the first year postdischarge: the prematurity and respiratory outcomes program (PROP) consortium. J Pediatr. 2019;208:e3.
Doyle LW, Cheong JL, Hay S, Manley BJ, Halliday HL. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Central Editorial Service, editor. Cochrane Database Syst Rev [Internet]. 2021 [cited 2025 May 25];2025. Available from: http://doi.wiley.com/10.1002/14651858.CD001145.pub5
Boscarino G, Cardilli V, Conti MG, Liguori F, Repole P, Parisi P, et al. Outcomes of postnatal systemic corticosteroids administration in ventilated preterm newborns: a systematic review of randomized controlled trials. Front Pediatr. 2024;12:1344337.
Ninan K, Liyanage SK, Murphy KE, Asztalos EV, McDonald SD. Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis. JAMA Pediatr. 2022;176:e220483.
Ahmet A, Rowan-Legg A, Pancer L. Adrenal suppression from exogenous glucocorticoids: recognizing risk factors and preventing morbidity. Paediatr Child Health. 2021;26:242–7.
Broersen LHA, Pereira AM, Jørgensen JOL, Dekkers OM. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100:2171–80.
Beuschlein F, Else T, Bancos I, Hahner S, Hamidi O, Van Hulsteijn L, et al. European society of endocrinology and endocrine society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol Metab. 2024;109:1657–83.
Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC, et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics. 2004;114:1649–57.
Waffarn F, Davis EP. Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations. Am J Obstet Gynecol. 2012;207:446–54.
Kervezee L, Romijn M, Van De Weijer KNG, Chen BSJ, Burchell GL, Tollenaar MS, et al. Development of 24-hour rhythms in cortisol secretion across infancy: a systematic review and meta-analysis of individual participant data. J Clin Endocrinol Metab. 2025;110:e515–24.
Iwata O, Okamura H, Saitsu H, Saikusa M, Kanda H, Eshima N, et al. Diurnal cortisol changes in newborn infants suggesting entrainment of peripheral circadian clock in utero and at birth. J Clin Endocrinol Metab. 2013;98:E25–32.
Ng PC, Lam CWK, Lee CH, Chan IHS, Wong SPS, Fok TF. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants. Neonatology. 2008;94:170–5.
Ford LR, Willi SM, Hollis BW, Wright NM. Suppression and recovery of the neonatal hypothalamic-pituitary-adrenal axis after prolonged dexamethasone therapy. J Pediatr. 1997;131:722–6.
Alkalay AL, Pomerance JJ, Puri AR, Lin BJ, Vinstein AL, Neufeld ND, et al. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone. Pediatrics. 1990;86:204–10.
Rizvi ZB, Aniol HS, Myers TF, Zeller WP, Fisher SG, Anderson CL. Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr. 1992;120:961–5.
Josephsen JB, Hemmann BM, Anderson CD, Hemmann BM, Buchanan PM, Williams HL, et al. Presumed adrenal insufficiency in neonates treated with corticosteroids for the prevention of bronchopulmonary dysplasia. J Perinatol. 2022;42:65–71.
Bowden SA, Henry R. Pediatric adrenal insufficiency: diagnosis, management, and new therapies. Int J Pediatr. 2018;2018:1–8.
Ng PC, Fok TF, Wong GWK, Lam CWK, Lee CH, Wong MY, et al. Pituitary-adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment. J Clin Endocrinol Metab. 1998;83:2390–3.
Ahmet A, Kim H, Spier S. Adrenal suppression: a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. Allergy Asthma Clin Immunol. 2011;7:13.
Improda N, Chioma L, Capalbo D, Bizzarri C, Salerno M. Glucocorticoid treatment and adrenal suppression in children: current view and open issues. J Endocrinol Invest. 2024;48:37–52.
Rosano K, Bery S, Marasch J, Farrell R, Mastrandrea LD, Ryan RM. Predicting iatrogenic adrenal insufficiency in neonates exposed to prolonged steroid courses: do cortisol levels help?. J Perinatol. 2024;44:1658–62.
Hyman SJ, Novoa Y, Holzman I. Perinatal endocrinology: common endocrine disorders in the sick and premature newborn. Pediatr Clin North Am. 2011;58:1083–98.
Burr WH, Gottschlich EA, Kist TW, Somberg CA, Frintner MP, Cull WL. Response rates and nonresponse bias among 20 years of pediatrician surveys. Acad Pediatr. 2025;25:102583.
Sand N, Silverstein M, Glascoe FP, Gupta VB, Tonniges TP, O’Connor KG. Pediatricians’ reported practices regarding developmental screening: do guidelines work? do they help? Pediatrics. 2005;116:174–9.
VanGeest JB, Johnson TP, Welch VL. Methodologies for improving response rates in surveys of physicians: a systematic review. Eval Health Prof. 2007;30:303–21.
Stokes F, Bailey L, Ganguli A, Davison A. Assessment of endogenous, oral and inhaled steroid cross-reactivity in the Roche cortisol immunoassay. Ann Clin Biochem Int J Lab Med. 2014;51:503–6.
Krasowski MD, Drees D, Morris CS, Maakestad J, Blau JL, Ekins S. Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clin Pathol. 2014;14:33.
Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Singh RJ, Colón-Franco JM, et al. New cutoffs for the biochemical diagnosis of adrenal insufficiency after ACTH stimulation using specific cortisol assays. J Endocr Soc. 2021;5:bvab022.
Haddad RA, Giacherio D, Barkan AL. Interpretation of common endocrine laboratory tests: technical pitfalls, their mechanisms and practical considerations. Clin Diab Endocrinol. 2019;5:12.
Torpy DJ, Lim WT. Glucocorticoid-induced adrenal suppression: physiological basis and strategies for glucocorticoid weaning. Med J Aust. 2023;219:444–7.
Nguyen MH, Zhang W, Pankratz N, Lane J, Chitiboina P, Faucz FR, et al. Exploratory study of the association of genetic factors with recovery of adrenal function in Cushing disease. J Endocr Soc. 2023;7:bvad046.
Lodish M, Dunn SV, Sinaii N, Keil MF, Stratakis CA. Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing’s disease. J Clin Endocrinol Metab. 2012;97:1483–91.
Romijn M, Van De Weijer KNG, Onland W, Rotteveel J, Van Kaam AH, Heijboer AC, et al. Falsely elevated cortisol serum levels in preterm infants due to use of immunoassay. Clin Chem Lab Med CCLM. 2023;61:e206–9.
LeDrew R, Bariciak E, Webster R, Barrowman N, Ahmet A. Evaluating the Low-Dose ACTH Stimulation Test in Neonates: Ideal Times for Cortisol Measurement. J Clin Endocrinol Metab. 2020;105:e4543–50.
Kwda A, Gldc P, Baui B, Kasr K, Ush SW, et al. Effect of long term inhaled corticosteroid therapy on adrenal suppression, growth and bone health in children with asthma. BMC Pediatr. 2019;19:411.
Silva C, Patel TJ, Lam C. Diagnosis of adrenal insufficiency in children: a survey among pediatric endocrinologists in North America. J Pediatr Endocrinol Metab [Internet]. 2022 [cited 2025 June 1];0. Available from: https://www.degruyter.com/document/doi/10.1515/jpem-2022-0444/html
Issa-El-Khoury K, Kim H, Chan ES, Vander Leek T, Noya F. CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma. Allergy Asthma Clin Immunol. 2015;11:9.
Ftouh S, Zucker M, Tran A, Tollerfield S, Williams K, Simpson H. Adrenal insufficiency: identification and management—summary of new NICE guidance. BMJ. 2025;389:r330.
Global Strategy for Asthma Management and Prevention, 2022 [Internet]. 2022. Available from: www.ginasthma.org
Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab. 1993;76:1505–10.
Ahmet A, Mokashi A, Goldbloom EB, Huot C, Jurencak R, Krishnamoorthy P, et al. Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children. BMJ Paediatr Open. 2019;3:e000569.
Hosokawa M, Ichihashi Y, Sato Y, Shibata N, Nagasaki K, Ikegawa K, et al. Incidence and risk factors for adrenal crisis in pediatric-onset adrenal insufficiency: a prospective study. J Clin Endocrinol Metab. 2024;109:e1602–7.
Rushworth RL, Torpy DJ, Stratakis CA, Falhammar H. Adrenal crises in children: perspectives and research directions. Horm Res Paediatr. 2018;89:341–51.
Miller BS, Spencer SP, Geffner ME, Gourgari E, Lahoti A, Kamboj MK, et al. Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings. J Investig Med. 2020;68:16–25.
Mushtaq T, Ali SR, Boulos N, Boyle R, Cheetham T, Davies JH, et al. Emergency and perioperative management of adrenal insufficiency in children and young people: British Society for Paediatric Endocrinology and Diabetes consensus guidance. Arch Dis Child. 2023;108:871–8.
Ahmet A, Gupta A, Malcolm J, Constantacos C. Approach to the patient: preventing adrenal crisis through patient and clinician education. J Clin Endocrinol Metab. 2023;108:1797–805.
Brown KA, Sauve RS. Evaluation of a caregiver education program: home oxygen therapy for infants. J Obstet Gynecol Neonatal Nurs. 1994;23:429–35.
Acknowledgements
We would like to thank faculty and staff at the Atrium Health Wake Forest Baptist Brenner Children’s NICU and Pediatric Endocrinology, the Atrium Health Levine Children’s Hospital NICU, the neonatologists at all participating CHNC centers, the CHNC leadership, and the CHNC Endocrinology focus group for their participation and feedback.
Author information
Authors and Affiliations
Contributions
CC and SCW designed the study. CC and SCW collected and analyzed the data. CC, SCW, and PMG equally contributed to the writing of the manuscript and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The manuscript is original, has not been published elsewhere, and is not currently under review by any other journal. All authors have read and approved the manuscript and agree with its submission to the Journal of Perinatology. All authors declare no competing financial or non-financial conflicts. All authors have read and approved the manuscript and agree with its submission to the Journal of Perinatology. All authors declare no competing financial or non-financial interests in relation to the work described.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Watson, S.C., Garg, P.M. & Constantacos, C. Neonatologists’ practices in screening and managing corticosteroid-induced adrenal insufficiency in the NICU- a multicenter study. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02592-2
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41372-026-02592-2